Loading stock data…
Loading stock data…
US$2.23
Get one email when LPCN crosses your level. Checked every 15 minutes during market hours.
▼ -0.06 (-2.62%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
41.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.02
Bearish momentumMACD below its signal line (-0.00).
50-day average
2.31
Price belowShort-term trend reference.
200-day average
4.64
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Lipocine Inc. is a pharmaceutical company specializing in the development and commercialization of innovative products through its proprietary oral drug delivery technology. The primary function of Lipocine Inc. is to improve patient compliance by converting drugs traditionally administered via injection into oral dosage forms. This technology enhances the absorption and bioavailability of oral medications, thereby addressing common challenges faced in drug delivery. Lipocine Inc.'s portfolio in…
www.lipocine.com2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-07-01)
2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
2 strong buy · 4 buy · 2 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-07 | -0.48 | -0.54 | ✗ Miss |
| 2026-03-10 | -0.61 | -0.42 | ✓ Beat |
| 2025-11-06 | -0.54 | -0.59 | ✗ Miss |
| 2025-08-05 | -0.4 | -0.41 | ✗ Miss |
| 2025-05-08 | -0.35 | -0.35 | ✓ Beat |
| 2025-03-13 | -0.4 | 0.33 | ✓ Beat |
| 2024-11-07 | -0.48 | -0.44 | ✓ Beat |
| 2024-08-08 | -0.78 | -0.56 | ✓ Beat |
Companies in the same industry, via Finnhub